PB
Schedule 13G filing
PharmAla Biotech Holdings Inc. disclosed a 10.1% stake in JUNS
PharmAla Biotech Holdings Inc. reported owning 10.1% of Jupiter Neurosciences, Inc. (JUNS) (132,867 shares) in a Schedule 13G filed Oct 26, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Oct 26, 2026
- Source
- Schedule 13G
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.